Read the latest positive news, breakthroughs, and inspiring stories about dravet syndrome, curated daily by BrightWire.
Scientists discovered that calming an overactive immune pathway in the brain reduces seizures in mice with Dravet syndrome, a severe form of childhood epilepsy. The breakthrough could lead to new treatments for the one-third of epilepsy patients who don't respond to current medications.
Scientists discovered that brain inflammation drives Dravet syndrome, a devastating form of childhood epilepsy, opening the door to treatments that could help thousands of children. By blocking a specific immune pathway, researchers reduced seizures in early studies.
A new gene therapy has reduced seizures by up to 85% in children with Dravet syndrome, a devastating form of epilepsy that begins in infancy. Kids in the trial are not only having fewer seizures but are making friends and enjoying life alongside their peers for the first time.
A breakthrough medication reduced seizures by 80% in children with a severe form of epilepsy, giving hope to thousands of families. The drug was well-tolerated by all 81 young patients in the trial.
A groundbreaking drug called zorevunersen slashed seizures by up to 91% in children with Dravet syndrome, a devastating form of epilepsy that causes developmental delays and sudden death. Unlike other treatments, this drug tackles the genetic root cause and could change the course of the disease.
Eight-year-old Freddie went from hundreds of seizures a day to just a couple per week thanks to a groundbreaking treatment targeting the root cause of Dravet syndrome. The experimental drug is giving families hope for near-normal lives after years of devastating, life-threatening fits.
A breakthrough treatment is transforming lives for children with Dravet syndrome, a severe form of epilepsy that can cause hundreds of seizures daily. Eight-year-old Freddie Truelove went from constant fits to just two seizures a week and is now skiing and climbing mountains.
A groundbreaking treatment could help children with Dravet syndrome not just reduce seizures, but actually improve cognitive development and daily living skills. For the first time, families facing this devastating genetic condition have hope for a disease-modifying therapy.